Third Harmonic Bio Analyst Ratings
Third Harmonic Bio Analyst Ratings
While ratings are subjective and will change, the latest Third Harmonic Bio (THRD) rating was a initiated with a price target of $0.00 to $30.00. The current price Third Harmonic Bio (THRD) is trading at is $4.30, which is within the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 12/16/2022 | -16.28% | Jefferies | $30 → $3.6 | Downgrades | Buy → Hold |
| 10/10/2022 | 597.67% | Jefferies | → $30 | Initiates Coverage On | → Buy |
| 10/10/2022 | 690.7% | Morgan Stanley | → $34 | Initiates Coverage On | → Overweight |
| 10/10/2022 | — | Cowen & Co. | Initiates Coverage On | → Outperform |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 12/16/2022 | -16.28% | 傑富瑞 | $30 → $3.6 | 評級下調 | 購買→Hold |
| 10/10/2022 | 597.67% | 傑富瑞 | → $30 | 開始承保 | →購買 |
| 10/10/2022 | 690.7% | 摩根士丹利 | → $34 | 開始承保 | →超重 |
| 10/10/2022 | — | 考恩公司 | 開始承保 | →跑贏大盤 |
What is the target price for Third Harmonic Bio (THRD)?
Third Harmonic Bio(THRD)的目標價格是多少？
The latest price target for Third Harmonic Bio (NASDAQ: THRD) was reported by Jefferies on October 10, 2022. The analyst firm set a price target for $30.00 expecting THRD to rise to within 12 months (a possible 597.67% upside). 3 analyst firms have reported ratings in the last year.
傑富瑞於2022年10月10日報道了Third Harmonic Bio(納斯達克：TRID)的最新目標價。這家分析公司將目標價定為30美元，預計THRD將在12個月內升至(可能上漲597.67)。3家分析公司在過去一年公佈了評級。
What is the most recent analyst rating for Third Harmonic Bio (THRD)?
分析師對Third Harmonic Bio(THRD)的最新評級是多少？
The latest analyst rating for Third Harmonic Bio (NASDAQ: THRD) was provided by Jefferies, and Third Harmonic Bio initiated their buy rating.
第三和諧生物(納斯達克：TRD)的最新分析師評級由傑富瑞提供，第三和諧生物啟動了他們的買入評級。
When is the next analyst rating going to be posted or updated for Third Harmonic Bio (THRD)?
下一次分析師對Third Harmonic Bio(THRD)的評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Third Harmonic Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Third Harmonic Bio was filed on October 10, 2022 so you should expect the next rating to be made available sometime around October 10, 2023.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公共財務報表，與Third Harmonic Bio的高管和客戶交談，以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。Third Harmonic Bio的最後一次評級是在2022年10月10日提交的，所以你應該預計下一次評級將在2023年10月10日左右的某個時候提供。
Is the Analyst Rating Third Harmonic Bio (THRD) correct?
分析師對Third Harmonic Bio(THRD)的評級正確嗎？
While ratings are subjective and will change, the latest Third Harmonic Bio (THRD) rating was a initiated with a price target of $0.00 to $30.00. The current price Third Harmonic Bio (THRD) is trading at is $4.30, which is within the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的Third Harmonic Bio(THRD)評級是以0.00美元至30.00美元的目標價啟動的。目前Third Harmonic Bio(THRD)的交易價格為4.30美元，在分析師的預測範圍內。
